As the deadlines for both US and European serialisation enforcement are imminent, companies have a lot to consider when attempting to implement the necessary changes to ensure compliance. Part of this is planning for future changes to the legal requirements, for example the introduction of three tier aggregation in the US by 2023. However, perhaps the most pressing challenge is ensuring companies can meet the enforcement deadlines in November 2018 and then in February 2019 with as little impact on supply as possible.
The biggest focus for companies at the moment should be ensuring compliance deadlines have as little impact on their operations as possible.
In this roundtable with Pharmaceutical Manufacturing and Packing Sourcer, Erik Haeffler, Vice President of manufacturing services and the Head of CSR at Recipharm, discusses the challenge of serialisation and how companies can ensure they limit the impact on their business.
Read the full article here: